publications

2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994


2000


Puppo F., Contini P., Ghio M., Brenci S., Scudeletti M., Filaci G., Ferrone S., Indiveri F. (2000) Soluble human major histocompatibility complex Class I molecules induce soluble Fas-ligand secretion and trigger apoptosis in activated CD8+ Fas(CD95)+ T lymphocytes.
Int. Immunol. 12: 195-203, 2000. I.F. 2.897

Ghio M., Contini P., Mazzei C., Brenci S., Filaci G., Indiveri F., Puppo F. (2000) Soluble HLA class I and Fas ligand molecules in blood components and their role in the immunomodulatory effects of blood transfusions. Leukemia and Lymphoma 37: 1-8, 2000. I.F. 1.140

Puppo F., Brenci S., Contini P., Bignardi D., Hamby C.V., Filaci G., Ghio M., Scudeletti M., Picciotto A., Indiveri F., Ferrone S. (2000) Increased B2-m -free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens.
Tissue Antigens 55: 333-341, 2000. I.F. 2.977

Campo N., Brizzolara S., Sinelli N., Puppo F., Campelli A., Indiveri F., Celle G., Picciotto A. (2000) Hepatitis G virus infection in intravenous drug users with or without human immunodeficiency virus infection.
Hepato-Gastroenterol., 47(35): 1385-8, 2000. I.F. 0.937

Puppo F., Torre F., Contini P., Ghio M., Brenci S., Brizzolara R., Sinelli N., Campo N., Indiveri F., Picciotto A. (2000) Soluble b2-m-associated and b 2-m-free HLA class I heavy chain serum levels in interferon-a nonresponder chronic hepatitis C patients, markers of immune activation, and response to antiviral retreatment.
J. Clin. Immunol. 20: 486-490, 2000. I.F. 2.427

Contini P., Ghio M., Merlo A., Brenci S., Filaci G., Indiveri F., Puppo F. (2000) Soluble HLA Class I/CD( ligation triggers apoptosis in EBV-specific CD8+ cytotoxic T lymphocytes by Fas/Fas-Ligand interaction.
Human Immunol. 61: 1347-1351, 2000.

Filaci G., Contini P., Barbera P., Bernardini L., Indiveri F. (2000) Autoantibodies to neutrophilic proteases in a case of panniculitis by deficit of a 1-antitrypsin.
Rheumatology 39: 1289-1290, 2000.

Indiveri F. (2000) Inibizione specifica della ciclossigenasi-2: esperienza clinica internazionale con celecoxib.
Ann. Ital. Med. Int. 15 (1): 77S-87S, 2000.

Pereno R., Giron-Michel J., Gaggero A., Cazes E., Meazza R., Monetti M., Monaco E., Mishal Z., Jasmin C., Indiveri F., Ferrini S., Azzarone B. (2000) IL-15/IL-15Ra intracellular trafficking in human melanoma cells and signal transduction through the IL-15Ra. Oncogene 19:
5153-5162, 2000.

Scudeletti M., Lanza L., Puppo F., Indiveri F. (2000) Apoptosi da corticosteroidi.
Progressi in Reumatologia vol. I, n. 5: 73-78, 2000.

Ghio M., Contini P., Puppo F., Indiveri F. (2000) Effetto immunomodulatorio delle emotrasfusioni e delle immunoglobuline per via endovenosa: ruolo delle molecole del complesso maggiore di istocompatibilità di classe I e Fas-ligando solubili.
Ann. Ital. Med. Int. 15: 70-74, 2000.

 


1999


Ghio M., Contini P., Mazzei C., Brenci S., Barberis G., Filaci G., Indiveri F.,Puppo F. (1999) Soluble HLA class I, HLA class II and Fas Ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood trasfusion.
Blood, 93: 1770-1777.

Filaci G., Cutolo M., Scudeletti M., Castagneto C., Derchi L., Gianrossi R., Ropolo F., Zentilin P., Sulli A., Ghio M., Puppo F., Indiveri F. (1999) Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and IL6 serum changes after one year therapy.
Rheumatology 38: 992-998, 1999. I.F. 2.845

Ghio M., Contini P., Mazzei C., Brenci S., Barberis G., Filaci G., Indiveri F.,Puppo F. (1999) Soluble HLA class I, HLA class II and Fas Ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood trasfusion.
Blood, 93:5,1770-1777,1999. I.F. 8.782

Lanza L., Scudeletti M., Monaco E., Monetti M., Puppo F., G. Filaci, Indiveri F. (1999) Possible differences in the mechanism(s) of action of different glucocorticoid hormone compounds. In neuroendocrine Immune basis of the rheumatic diseases
Vol. 876 of the Annals of the New York Academy of Sciences June 22, pagg. 193-197, 1999. I.F. 0.964

Pereno R., Gaggero A., Scudeletti M., Lanza L., Meazza R., Mishal Z., Jasmin C., Indiveri F., Ferrini S., Azzarone B. (1999) IL-15/IL-15Ra intracellular trafficking in human cells and protection from apoptosis.
In neuroendocrine Immune basis of the rheumatic diseases Vol. 876 of the Annals of the New York Academy of Sciences June 22, pagg. 193-197, 1999. I.F. 0.9647

Puppo F., Costa M., Contini P., Brenci S., Cevasco E., Ghio M., Norelli R., Benussan A., Capitano,G.L., Indiveri F. (1999) Determination of soluble HLA-G and HLA-A,-B,-C molecules in pregnancy.
Transplantation Proceedings 31, 1841-1843, 1999. I.F. 0.590

Puppo F., Bignardi D., Contini P., Hamby C.V., Brenci S., Lanza L., Ghio M., Scudeletti M., Indiveri F., Ferrone S. (1999) 2ß µ free HLA Class I heavy chain levels in sera of healthy indiduals. Lack of association with associated HLA Class I heavy chain levels and HLA phenotype.
Tissue Antigens 53:253-262,1999. I.F. 2.977

Scudeletti M., Lanza L., Monaco E., Monetti M., Puppo F., Filaci G., Indiveri F. (1999) Immune Regulatory properties of corticosteroids: prednisone induces apoptosis of human T lymphocytes following the CD3 down-regulation.
In neuroendocrine Immune basis of the rheumatic diseases Vol. 876 of the Annals of the New York Academy of Sciences June 22, pagg. 164-179, 1999. I.F. 0.964

Setti M., Bignardi D., Ballestrero A., Ferrando F., Musselli C., Blanchi S., Basso M., Bosco O., Balleari E., Patrone F., Indiveri F. (1999) The induction of distinct cytokine cascade correlates with different effects of granulocyte-colony stimulating factor and granulocyte-macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer.
Cancer Immunol Immunother 48:287-296, 1999. I.F. 2.293

Setti M., Alvaro MR., Imperato A., Bosco O., Brenci S., Puppo F., Indiveri F. (1999) Decreased surface antigen density on elderly human's lymphocytes.
Annali Italiani di Medicina Interna 14: 246-252, 1999.

Filaci G., Cutolo M., Scudeletti M., Castagneto C., Derchi L.E., Ginarossi R., Ropolo F., Zentilin P., Sulli A., Murdaca G., Ghio M., Puppo F., Indiveri F. (1999) Clinical evaluation of systemic sclerosis: a comprehensive panel of diagnostic tests to assess skin, microvascular and visceral involvement.
Annali Italiani di Medicina Interna, vol. 14: 79-85, 1999.

 


1998


Barzegar C., Meazza R., Pereno R., Pottin-Clemenceau C., Scudeletti M., Brouty-Boye D., Doucet C., Taoufik Y., Ritz J., Musselli C., Mishall Z., Jasmin C., Indiveri F., Ferrini S., and Azzarone B. (1998) Il-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops.
Oncogene 16: 2503-2512..

Filaci G., Cutolo M., Scudeletti M., Castagneto C., Sulli A., Parodi M.N., Puppo F., Indiveri F. (1998) Cyclosporin and iloprost treatment of systemic sclerosis.
10th International Congress of Immunology
New Delhi, India 1-6 November.

Filaci G., Contini P., Grasso I., Bignardi D., Ghio M., Lanza L., Scudeletti M., Puppo F., Bolognesi M., Accolla R.S., and Indiveri F. (1998) Double stranded deoxyribonucleic acid binds to human histocompatibility leukocyte antigen class II molecules and inhibitis human histocompatibility leukocyte antigen class II mediate antigen presentation.
10th International Congress of Immunology New Delhi, India 1-6 November.

Ghio M., Contini P., Mazzei C., Barbieris G., Brenci S., Filaci G., Bignardi D., Indiveri F., and Puppo F. (1998) Elevated amounts of soluble HLA class I and soluble Fas ligand molecules in blood components.
10th International Congress of Immunology New Delhi, India 1-6 November.

Scudeletti M., Lanza L., Peirano L., Bosco O., Puppo F., Filaci G., Indiveri F. (1998) CD3 downregulation is required for prednisone induced apoptosis in human lymphocytes.
Annals of the New York Academy of Sciences in press.

Filaci G., Cutolo M. Scudeletti M., Castagneto C., Derchi L., Gianrossi R., Ropolo F., Zentilin P., Sulli A., Ghio M., Puppo F., Indiveri F. (1998) Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and IL6 serum changes after one year therapy.
British Journal of rheumatology. Submitted.

Filaci G., Contini P., Barbera P., Bernardini L., Indiveri F. (1998) Autoantibodies to neutrophilic proteases in a case of panniculitis by deficit of a1-antitrypsn.
Arthritis and rheumatsm. Submitted.

Puppo F ., Bignardi D., Contini P., Hamby C.V., Brenci S., Lanza L., Ghio M., Scudeletti M., Indiveri F., Ferrone S., 2ß µ free HLA Class I heavy chain levels in sera of healthy indiduals. Lack of association with associated HLA Class I heavy chain levels and HLA phenotype.
In press.

Filaci G., Contini P., Grasso I., Bignardi D., Ghio M., Lanza L., Scudeletti M., Puppo F., Bolognesi M., Accolla R.S., Indiveri F. (1998) ds DNA binds to HLA class II molecules and inhibits HLA class II mediated antigen presentation.
Eur. J. Immunol., 28: 3968-3979.

Puppo F., Costa M. Contini P., Brenci S., Cevasco E., Ghio M., Norelli R., Benussan A., Capitano G.L., Indiveri F. Quantification of soluble HLA-G and HLA-A,-B,-C molecules in pregnancy.
Trasplant. Proc., In press.

McDermott J.L., Giri A.A., Giacomini P., Pietrapiana D., Martini D., Indiveri F., Puppo F., Campelli A., Tagliaferro L. Cara A., Varnier O.E. New aspects and perspectives in AIDS diagnosis.
Alpe Adia Microb. J., In press.

Puppo F., Ghio M., Contini P., Brenci S., Bignardi D., Filaci G., Scudeletti F., Indiveri F. (1998) Immunoregulatory role of soluble HLA molecules: a new skin for an old subject?
Arch. Immunol. et Ther. Exp. 46: 157-160.

Musso NR., Brenci S., Indiveri F., Lotti G. (1998) Acetylcholine-induced, calcium-dependent norepinephrine outflow from peripheral human lymphocytes.
Journal of Neuroimmunology 87: 82-87.

 


1997


Doucet C., Meazza R., Pottin-Clemenceau C., Scudeletti M., Brouty-Boye D., Ferrini S., Alileche A., Taoufik Y., Jasmin C., Azzarone B., and Indiveri F. (1997) Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
Melanoma Research 7: (suppl. 2) S7-S17.

Indiveri F., Setti M. (1997) Immunocompetenza ed invecchiamento.
Giorn. Geront. Vol. 45 pag. 547-551.

Puppo F., Brenci S., Bosco O., Lanza L., Barocci S., Nocera A., Ghio M., Contini P., Setti M., Scudeletti M., Indiveri F. (1997) Downregulation of HLA Class I antigen expression in CD4+ T lymphocytes from HIV type 1-infected individuals.
AIDS research and human retroviruses. 13:17,1509-1516.

Filaci G., Pelli N., Sacco T., Contini P., Lanza L., Picciotto A., Scudeletti M., Puppo F., Castiglioni G., Indiveri F. (1997) S-Adenosil-L-methionine is able to reverse the immunosuppressive effects of chenodeoxycholic acid in vitro.
Int. J. Immunopharmac. 19:157-165.

Cimino M., Accardo S., Scudeletti M., Indiveri F. (1997) The diagnosis of polymyalgia rheumatica in patients with a low erythrocyte sedimentation rate: comment on the article by Helfgott and Kieval.
Arthritis & Rheumatism 40: 1726-1727.

Puppo F., Indiveri F., Scudeletti M., Ferrone S. (1997) Soluble HLA antigens: new roles and uses.
Immunology Today 18: 154-155.

Perosa F., Scuedeletti M., Indiveri F. and Dammacco F. (1997) Anti-idiotypic monoclonal antibody (mAb) to anti-CD4 mAb assurogate of human CD4 antigen (Ag) for active immunotherapy of autoimmune diseases.
Elsevier Science B.V. 239-254.

Filaci G., Contini P., Brenci S., Gazzola P., Lanza L., Scudeletti M., Indiveri F., Mancardi G.L., Puppo F. (1997) Soluble HLA class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients.
Human Immunology 54: 54-62..

Musso NR., Brenci S., Indiveri F. Lotti G. (1997) L-tyrosine and nicotine induce synthesis of L-Dopa and norepinephrine in human lymphocytes.
Journal of Neuroimmunology 74: 117-120.

Perosa F., Scudeletti M., Imro A.M., Dammacco F., Luccarelli G., Indiveri F. (1997) Anti-CD4 monoclonal antibody (MAB) and anti-idiotypic MAB to anti-CD4 in the therapy of autoimmune diseases.
Clinical and Experimental Rheumatology 15:201-210.

Parodi M.N., Castagneto C., Filaci G., Murdaca G., Puppo F., Indiveri F., and Scudeletti M. (1997) Plicometer skin test: a new techinique for the evaluation of cutaneous involvement in Systemic Sclerosis.
British Journal of Rheumatology. 36: 244-250.

 


1996


Puppo F., Brenci S., Ghio M., Bignardi D., Contini P., Bacigalupo A., Van Lint M.T., Filaci G., Scudeletti M., Ferrone S., Indiveri F. (1996) Monitoring of serum HLA class I antigen levels in allogeneic bone marrow transplantation.
Molecular Biology of Hematopoiesis 5 edit by Abraham et al. Plenum Press pag. 101-105.

Ciotti P., Imro M.A., Scudeletti M., Rainero L, Defferrari R., Ghiorzo P., Indiveri F. and Bianchi-Scarra'. (1996) G. MEL-P, a GM-CSF-producing human melanoma cell line.
Melanoma Research 6: 203-213.

Filaci G., Grasso I., Contini P., Imro M.A., Lanza L., Scuedeletti M., Rossi E., Puppo F., Damasio E., Indiveri F. (1996) DsDNA and nucleohistrone reactive T lymphocytes in patients affected by SLE: correlation with the clinical activity of the disease.
Clinical and Exp. Rheumatol. 14: 543-550.

Scudeletti M., Musselli C., Lanza L., Puppo F., Indiveri F. (1996) Attivita' immunologica dei corticosteroidi. In Recenti Progressi in Medicina.
Il Pensiero Scientifico Ed. Roma pag. 508-515.

Musselli C., Scudeletti M., Lanza L., Peirano L., Puppo F., Indiveri F. (1996) I corticosteroidi: effetti sulla risposta immune ed implicazioni terapeutiche. In Clinica Immunologica. Dammacco F., Danieli G. Ed.
Il Pensiero Scientifico Editore. Roma pag. 281-306.

Musso N.R., Brenci S., Setti M., Indiveri F., and Lotti G. (1996) Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes.
J. Clinical End. Met. 81:3553-3557.

Perosa F., Scudeletti M., Imro M.A., Dammacco F. and Indiveri F. (1996) Human CD4-Internal antigen anti-idiotypic monoclonal antibody. Induction of a CD4-Specific response in humans.
The Journal of Immunology 156: 3565-3569.

Farinelli A., Setti Maurizio, Puppo F., Scudeletti M., De Martini A., Balestra V., Indiveri F. (1996) Quantitative analyses of plasma opsonizing activity and polymorphonuclear cell response during phagocytosis: standardisation of chemiluminescent method.
APMIS 104: 500-508.

Puppo F., Scudeletti M., Indiveri F. and Ferrone S. (1996) Serum HLA class I: clinical significance in organ transplantation.
Immunology Today 17: 2, 99.

Lanza L., Scudeletti M., Puppo F., Bosco O., Peirano L., Filaci G., Fecarotta M., Vidali E., Indiveri F. (1996) Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes.
Clinical and Experimental Immunology, 103: 482-490.

Han D., Pottin-Clemenceau C., Imro M.A., Scudeletti M., Doucet C., Puppo F., Brouty-Boye D., Vedrenne J., Sahraoui Y., Brailly H., Poggi A., Jasmin C., Azzarone B., and Indiveri F. (1996) IL2 triggers a tumor progression process in a melanoma cell line MELP, derived from a patient whose metastasis increased in size during IL2/IFNa biotherapy.
Oncogene 12: 1015-1023.

Azzarone B., Pottin-Clemenceau C., Krief P., Rubinstein E., Jasmin C., Scudeletti M., and Indiveri F. (1996) Are interleukin-2 and interleukin-15 tunor promoting factors for human non-hematopoiet ic cells?
Eur. Cytokine Netw. 7: 1, 27-36.

Puppo F., Brenci S., Ghio M., Bignardi D., Contini P., Bacigalupo A., Van Lint M.T., Scudeletti M., Ferrone S., and Indiveri F. (1996) Serum HLA Class I antigen level in allogeneic bone marrow transplantation: a marker of acute GVHD.
Bone Marrow Transplantation 17:753-758.

 


1995


Puppo F., Brenci S., Lanza L., Peirano L., Contini P., Ghio M., Bignardi D., Filaci G., Scudeletti M., Indiveri F. (1995) Increased turnover of HLA class I antigens in peripheral blood mononuclear cells from HIV-positive subjects.
Fundamental and Clinical Immunology 3:4,163-170.

Balleari E., Timitilli S., Bason C., Puppo F., Massa G., Brenci S., Indiveri F., Ghio R. (1995) Altered production of cytokines modulating hematopoiesis by cultured T lymphocytes of subjects with human immunodeficiency virus (HIV) infection.
Foundamental and Clinical Immunology 3: 124-129.

Puppo F., Brenci S., Bosco O., Lanza L., Peirano L., Nocera A., Barocci S., Scudeletti M., Indiveri F. (1995) Ridotta espressione di antigeni HLA di classe I nei linfociti CD4+ di soggetti HIV-positivi.
Atti del XIV Congresso Nazionale della Societa' Italiana di Immunologia e Immunopatologia, Monduzzi Editore, Bari 1-4 Ottobre.

Lanza L., Peirano L., Bosco O., Mazzarello M., Filaci G., Puppo F., Scudeletti M., Indiveri F. (1995) Il prednisone induce apoptosi in linfociti T umani attivati attraverso la modulazione del Tcr e di altri recettori di membrana.
Atti del XIV Congresso Nazionale della Societa' Italiana di Immunologia e Immunopatologia, Monduzzi Editore, Bari 1-4 Ottobre.

Puppo F., Ghio M., Brenci S., Contini P., Bosco O., Zicca A., Scudeletti M., Indiveri F. (1995) Molecole HLA di classe I solubili inducono apoptosi in linfociti CD8+ attivati con PHA.
Atti del XIV Congresso Nazionale della Societa' Italiana di Immunologia e Immunopatologia, Monduzzi Editore, Bari 1-4 Ottobre.

Filaci G., P. Contini, P., Brenci S, Lanza L., Scudeletti M., Indiveri F., Puppo F. (1995) Elevate concentrazioni sieriche di molecole solubili di HLA-DR in corso di infezione da HIV, di rigetto acuto di trapianto d'organo e di GVHD.
Atti del XIV Congresso Nazionale della Societa' Italiana di Immunologia e Immunopatologia, Monduzzi Editore, Bari 1-4 Ottobre.

Imro M.A., Castagneto C., Bosco O., Modena P., Lanza L., Puppo F., Filaci G., Indiveri F. (1995) CD4+ Tho cell clones isolated from a metastatic limp node of a melanoma patient, possess cytolytic function.
Cancer Immunol. Immunother. 41: 210-216.

Lanza L., Peirano L., Bosco O., Contini P., Filaci G., Setti M., Puppo F., Indiveri F., Scudeletti M. (1995) Interferons up-regulate with different potency HLA class I antigen expression in M14 melanoma cell line. Possible interaction with glucocorticoid hormones.
Cancer Immunol. Immunother. 41: 23-28.

Filaci G., Contini P., Brenci S., Lanza L., Scudeletti M., Indiveri F., Puppo F. (1995) Increased serum concentration of soluble HLA-DR antigens in HIV infection and following -transplantation.
Tissue Antigens 46: 117-123.

Filaci G., Grasso I., Vignola S., Imro M.A., Scudeletti M., Puppo F., Indiveri F. (1995) DsDNA-specific T-cell lines in SLE patients: data suggesting their oligoclonatily.
Ann. N.Y. Acad. Sci. 756: 428-430.

Puppo F., Picciotto A., Brenci S., Varagona G., Scudeletti M., Ghio M., Balestra V., Celle G., Indiveri F. (1995) Behaviour of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor merker of response?
J. Clin. Immunol. 15: 179-184.

Puppo F., Scudeletti M., Indiveri F., Ferrone S. (1995) Serum HLA class I antigens: markers and modulators of an immune response?
Immunol. Today 16: 124-127.

Renna Mollajoni E., Puppo F., Brenci S., Scudeletti M., Cinti P., Alfani D., Indiveri F., Cortesini R. (1995) Serum HLA class I soluble antigens: a marker of acute rejection following liver transplantation.
Transpl. Proc. 27:1155-1156
.

 


1994


Zentilin P., Savarino V., Puppo F., Scudeletti M., Indiveri F. (1994) Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al.
Arthritis Reum. 37: 301.

Scudeletti M., Filaci G.,Puppo F., Lanza L., Bosco O., Minetti L., Brando B., Imbimbo B., and Indiveri F. (1994) Effect of intravenous deflazacort 21-hemisuccinate on human peripheral blood lymphocytes.
Foundamental and Clinical Immunology Vol. 3: 153-160.

Setti M., Scudeletti M., Indiveri F. (1994) Biological response modifiers. Clinical applications.
Mediterranean Journal of infectious and parasitic diseases. vol.9,194.

Setti M., Balleari E., Indiveri F. (1994) Pathophysiological bases and approach to clinical use of thymic hormones.
Seminars in clinical immunology 7: 49-64.

Saririan K.K., Contini P., Indiveri F., Gross P.A., and Riusso C. (1994) Serum HLA class I levels in elderly humans: Utilization in follwing the response to influenza vaccine.
Human Immunology 54: 18, 1305-1312..

Giglio T., Imro M.A., Filaci G., Scudeletti M., Puppo F., De Cecco L.,Indiveri F., Costantini S. (1994) Immune cell circulating subsets are affected by gonadal function.
Life Science . 54: n. 18, 1305-1312..

Puppo F., Pellicci R., Brenci S., Nocera A., Morelli N., Dardano G., Bertocchi M., Antonucci A., Ghio M., Scudeletti M., Barocci S. , Valente U., Indiveri F. (1994) HLA class I soluble antigens serum levels in liver transplantation . A predictor marker of acute rejection.
Human Immunology, 40: 166-170.

Puppo F., Brenci S., Lanza L., Bosco O., Imro M.A., Scudeletti M., Indiveri F., Ferrone S. (1994) Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progression .
Human Immunology,40:259.

Puppo F., Brenci S., Montinaro E., Lanza L., Contini P., Scudeletti M., and Indiveri F. (1994) Inhibition of alloreactive cytotoxic T cell activity by HIV-positive sera: potential role of circulating solubile HLA class I molecules. AIDS
Research and human retroviruses Vol, 10 9:1061-1064.

Scudeletti M., Indiveri F., Filaci G., Imro M.A., Lanza L., Puppo F. (1994) Glicocorticoidi nelle malattie autoimmuni Atti 21°
Congresso della Societa' Italiana di Allergologia ed Immunologia Clinica. pag. 275-278.

Indiveri F., Puppo F. (1994) Disregolazione della sintesi e del rilascio degli antigeni HLA I nella infezione da HIV. Possibile ruolo nella patogenesi della immunodeficienza.
Atti 21° Congresso della Soc. Italiana di Allergologia ed Immunologia Clinica. pag. 301-304.